Buy or sell Bayer stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Bayer Stock
Multinational pharmaceutical and life sciences company
About Bayer Stock
Bayer operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, cosmetics, and self-care solutions in the dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, cold and cough, foot care, and sun protection categories. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to veterinarians. Bayer distributes its products through wholesalers, pharmacies, supermarket and drugstore chains, online and other retailers, and hospitals, as well as directly to farmers. Friedrich Bayer and Johann Friedrich Weskott founded Bayer on August 1, 1863. It has its headquarters in Leverkusen in Germany.
Funding History
April 2018 | $3.0B |
---|
Management
Global Head of Digital Health and Innovation
Eugene Borukhovich
Head at Bayer Venture Investments
Juergen Eckhardt
Global Head of Digital Transformation
Saskia Steinacker
Head of Leaps
Axel Bouchon
Head of Brand Management
Jun Tang
Crop Science Division, representing SETAC DRAW
Andrew Chapple
Head of IT Business Partnering Research
Angeli Möller
General Counsel
Xi Zhang
Global Corporate Web and Social Strategy Lead
Kate Humphrey
Director of Pharmaceuticals Clinical Project Management
Tarja Jalava
Press
BuzzFeed - Apr, 8 2020
Wall Streets Journal - Apr, 3 2020
Wall Streets Journal - Mar, 13 2020
New York Times - Mar, 12 2020
Wall Streets Journal - Feb, 26 2020
Wall Streets Journal - Jan, 27 2020
Wall Streets Journal - Jan, 18 2020
Forbes - Nov, 7 2019
Forbes - Nov, 7 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Bayer or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase